Gilad Oren
Aprea Therapeutics, Inc. · President/CEO
Gilad Oren is listed in filings as President/CEO at Aprea Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 16, 2026, including purchase activity. Recent filings connect the profile to Aprea Therapeutics, Inc. (APRE). The current snapshot covers public activity from Oct 15, 2024 to Mar 16, 2026. Reported amounts are shown as $61.7K to $21.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $221.5k shares | BuyDec 10, 2025 | $0.0001 | $0.6816 | |
| $22k21.5k shares | BuyDec 10, 2025 | $1.04 | $0.6816 | |
| $4.5k2.5k shares | BuyApr 3, 2025 | $1.80 | $0.6816 | |
| $5.6k3k shares | BuyApr 3, 2025 | $1.87 | $0.6816 | |
| $2k500 shares | BuyOct 23, 2024 | $3.92 | $0.6816 | |
| $725250 shares | BuyOct 15, 2024 | $2.90 | $0.6816 | |
| $2.6k1k shares | BuyOct 14, 2024 | $2.59 | $0.6816 | |
| $381150 shares | BuyOct 10, 2024 | $2.54 | $0.6816 |